Featured Research

from universities, journals, and other organizations

DNA Blueprint Of Deadly Cholera Bacterium Unveiled

Date:
August 3, 2000
Source:
National Institute Of Allergy And Infectious Diseases
Summary:
As reported in this week's issue of the journal Nature, scientists have determined the entire order of paired chemical building blocks that make up the DNA of the deadly cholera bacterium, an ancient infectious foe.

As reported in this week's issue of the journal Nature, scientists have determined the entire order of paired chemical building blocks that make up the DNA of the deadly cholera bacterium, an ancient infectious foe. The comma-shaped microbe, Vibrio cholerae, causes a severe diarrheal disease that has been endemic in southern Asia for at least 1,000 years. Since 1817, it has spread worldwide to cause seven pandemics. Between outbreaks, the organism thrives in brackish waters in both harmless and disease-causing forms.

"Determining the genomic sequence of medically important pathogens such as Vibrio cholerae holds enormous promise for helping us fight some of the world's most intractable infectious diseases," comments Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), which funded the project. "Besides contributing to our understanding of how a microbe causes disease and survives in the environment, sequencing studies enable scientists to locate genes that may lead to potential new targets for vaccine candidates, drugs and diagnostic tools.

"Cholera has been extensively studied by many people, yet important new discoveries continue to be made," he adds. "Having the sequence available will facilitate these efforts immensely."

A talented team of cholera and genome sequencing experts contributed to the success of the project. They include John Mekalanos, Ph.D., of Harvard Medical School, a renowned microbiologist who probes how bacterial virulence factors cause disease; National Science Foundation Director Rita Colwell, Ph.D., of the University of Maryland, an expert in how V. cholerae persists in the environment; and genomics experts Claire M. Fraser, Ph.D., and John Heidelberg, Ph.D., of The Institute for Genomic Research (TIGR) in Rockville, Maryland .

The project began in late 1996, one of the earliest microbial genome sequencing efforts financed by NIAID, and its outcome has been long-awaited. Since that time, NIAID has rapidly expanded its portfolio of such grants, and they now number more than 30.

One of the most unusual findings of the cholera project is that instead of having one circular chromosome, like most bacteria, the organism has two, notes Dennis Lang, Ph.D., NIAID's bacterial and viral enteric diseases program officer. "When the team became aware of new research indicating that cholera strains may have two chromosomes, they rapidly assembled the final sequence into two separate elements."

The larger chromosome, comprising nearly 3 million base pairs, contains most of the organism's critical genes, including those coding for disease-causing toxins and proteins that carry out essential cell functions. The smaller chromosome is roughly one-third its size. "Both chromosomes are essential," says Dr. Lang. "You couldn't do away with either one of them and have the organism be viable."

Besides illuminating the bacterium's role in disease, the sequence information will enable scientists to investigate specific questions about how V. cholerae survives and persists in the environment, which it sometimes does by colonizing algae and other sea life. "Hundreds of different strains of the bacterium exist, and how they interact and evolve is largely a mystery," Dr. Lang notes.

Dr. Colwell and others have long believed that the bacterium enters a quiescent state where, much like bacterial spores, it is alive but fails to multiply unless triggered by specific environmental conditions. "The authors of the Nature paper found some genes in the cholera genome," Dr. Lang says, "that appear to be related to genes from sporulating bacteria. What role these cholera genes may play in that quiescent state, if it exists, remains to be seen, but this information will provide much fodder for that research."

The V. cholerae strain that was sequenced, a virulent El Tor strain used for many years in clinical studies, is also a strain that NIAID has produced in quantity and supplies to investigators worldwide for vaccine studies.

Cholera has a rapid onset and most often occurs in epidemics spread through contaminated water. Oral rehydration is an effective treatment, but left untreated, cholera causes severe diarrhea that has a high mortality rate, particularly in young children. According to information reported to the World Health Organization in 1999, nearly 8,500 people died and another 223,000 were sickened with cholera worldwide.


Story Source:

The above story is based on materials provided by National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Allergy And Infectious Diseases. "DNA Blueprint Of Deadly Cholera Bacterium Unveiled." ScienceDaily. ScienceDaily, 3 August 2000. <www.sciencedaily.com/releases/2000/08/000803075719.htm>.
National Institute Of Allergy And Infectious Diseases. (2000, August 3). DNA Blueprint Of Deadly Cholera Bacterium Unveiled. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2000/08/000803075719.htm
National Institute Of Allergy And Infectious Diseases. "DNA Blueprint Of Deadly Cholera Bacterium Unveiled." ScienceDaily. www.sciencedaily.com/releases/2000/08/000803075719.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins